ODDB.org: Open Drug Database

Rapiscan 400 µg/ 5 ml, Injektionslösung -

Swissmedic Key	66137001	Registration Holder	GE Healthcare AG
Name	Rapiscan 400 µg/ 5 ml, Injektionslösung	Date of registration	28.07.2017
		Introduction of Sequence	28.07.2017
ATC-Classification	Regadenoson (C01EB21)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	14.03.	Show package size
Index Therapeuticus (Swissmedic)	14.03.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	90.30	Limitation	No

Deductible	10 %	Consumer price	114.60
Feedback	FB	Daily cost
GTIN	7680661370013	Medication Code	Synthetika
Pharmacode	7265003	Disponibility	●

Composition

regadenosonum 400 µg, dinatrii phosphas, natrii dihydrogenophosphas, propylenglycolum 750 mg, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 19 mg.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Regadenosonum	400µg / 5ml

BAG: Active Agent	Dose
Regadenosonum	400 mcg

Inactive agents	Dose
Dinatrii Edetas
Disodium Phosphate
Natrii Dihydrogenophosphas
Propylenglycol	750mg / 5ml

Source

Data was imported : 07.07.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH